ADVANCELL generates proprietary drug candidates by leveraging an innovative nanosystems drug delivery technology to reformulate and reposition existing drugs.
The company focuses on oncological and dermatological indications. Projects in these areas continue to reach the evaluation and feasibility stage.
In addition, other indications with significant market potential and considerable unmet medical need are also being evaluated due to the versatility of the nanosystem platform.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
